AdvanSix Inc. Earnings Per Share Disclosure
| Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Basic | |||||||||||||||||
Net Income | $ | 49,286 | $ | 44,149 | $ | 54,623 | |||||||||||
Weighted average common shares outstanding | 26,901,046 | 26,828,338 | 27,302,254 | ||||||||||||||
EPS – Basic | $ | 1.83 | $ | 1.65 | $ | 2.00 | |||||||||||
| Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Diluted | |||||||||||||||||
Net Income | $ | 49,286 | $ | 44,149 | $ | 54,623 | |||||||||||
Weighted average common shares outstanding – Basic | 26,901,046 | 26,828,338 | 27,302,254 | ||||||||||||||
Dilutive effect of unvested equity awards | 426,403 | 426,875 | 705,376 | ||||||||||||||
Weighted average common shares outstanding – Diluted | 27,327,449 | 27,255,213 | 28,007,630 | ||||||||||||||
EPS – Diluted | $ | 1.80 | $ | 1.62 | $ | 1.95 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 20, 2026 | Showing above |
| 2023 | Feb 16, 2024 | |
| 2022 | Feb 17, 2023 | |
| 2021 | Feb 18, 2022 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.